Variant-specific therapy for long QT syndrome type 3
Heart Rhythm · 2023
DOI: 10.1016/j.hrthm.2023.02.013 ↗Kurz gefasst
Editorial in der Zeitschrift Heart Rhythm, 2023. Verfasst von Oliver M Moore und 2 weiteren Autor:innen. Beteiligte Einrichtung: Cardiovascular Research Institute, Baylor College of Medicine, Houston, Texas; Department of Integrative Physiology, Baylor College of Medicine, Hous…. Hauptthemen laut MEDLINE: Long QT Syndrome. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 10 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS, NIGMS NIH HHS, National Institutes of Health.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Cardiovascular Research Institute, Baylor College of Medicine, Houston, Texas; Department of Integrative Physiology, Baylor College of Medicine, Houston, Texas; Department of Neuroscience, Baylor College of Medicine, Ho…
- Cardiovascular Research Institute, Baylor College of Medicine, Houston, Texas; Department of Integrative Physiology, Baylor College of Medicine, Houston, Texas.
Förderung
- NHLBI NIH HHS
- NIGMS NIH HHS
- National Institutes of Health
- Foundation for the National Institutes of Health
- Baylor College of Medicine
Zitieren
APA
Moore, O. M., Dorn, L. E., & Wehrens, X. H. T. (2023). Variant-specific therapy for long QT syndrome type 3. Heart Rhythm. https://doi.org/10.1016/j.hrthm.2023.02.013
Vancouver
Moore OM, Dorn LE, Wehrens XHT. Variant-specific therapy for long QT syndrome type 3. Heart Rhythm. 2023. doi:10.1016/j.hrthm.2023.02.013
BibTeX
@article{Moore2023,
author = {Moore, Oliver M and Dorn, Lauren E and Wehrens, Xander H T},
title = {Variant-specific therapy for long QT syndrome type 3},
journal = {Heart Rhythm},
year = {2023},
doi = {10.1016/j.hrthm.2023.02.013}
}
EUVIMED